Victronectin (Vtn) is found to co-localize within Aβ deposits in AD and abnormal deposits associated with other age-related degenerative diseases, through calcium ion-binding and H-X domains [40,41,42], and is also found to be up-regulated in our transgenic mice. Here, VTN is linked to Alzheimer disease.